[go: up one dir, main page]

ZA902086B - Novel insulin compounds - Google Patents

Novel insulin compounds

Info

Publication number
ZA902086B
ZA902086B ZA902086A ZA902086A ZA902086B ZA 902086 B ZA902086 B ZA 902086B ZA 902086 A ZA902086 A ZA 902086A ZA 902086 A ZA902086 A ZA 902086A ZA 902086 B ZA902086 B ZA 902086B
Authority
ZA
South Africa
Prior art keywords
image
insulin compounds
novel insulin
coded
amino acid
Prior art date
Application number
ZA902086A
Other languages
English (en)
Inventor
Per Balschmidt
Balschmidt Per
Finn Benned Hansen
Benned Hansen Finn
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA902086B publication Critical patent/ZA902086B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA902086A 1989-03-20 1990-03-19 Novel insulin compounds ZA902086B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK134189A DK134189D0 (da) 1989-03-20 1989-03-20 Insulinforbindelser

Publications (1)

Publication Number Publication Date
ZA902086B true ZA902086B (en) 1990-11-28

Family

ID=8103787

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902086A ZA902086B (en) 1989-03-20 1990-03-19 Novel insulin compounds

Country Status (23)

Country Link
US (1) US5430016A (fr)
EP (1) EP0463072B1 (fr)
JP (1) JPH04503808A (fr)
KR (1) KR920701250A (fr)
CN (1) CN1045793A (fr)
AT (1) ATE116661T1 (fr)
AU (1) AU637365B2 (fr)
CA (1) CA2049961A1 (fr)
DD (1) DD298788A5 (fr)
DE (1) DE69015811T2 (fr)
DK (2) DK134189D0 (fr)
ES (1) ES2068384T3 (fr)
FI (1) FI914419A7 (fr)
GR (1) GR1002545B (fr)
HU (1) HUT58349A (fr)
IE (1) IE66564B1 (fr)
IL (1) IL93792A0 (fr)
NO (1) NO300640B1 (fr)
NZ (1) NZ232953A (fr)
PT (1) PT93502B (fr)
WO (1) WO1990011299A1 (fr)
YU (1) YU53290A (fr)
ZA (1) ZA902086B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
CA2306905A1 (fr) 1997-10-24 1999-05-06 Eli Lilly And Company Analogues d'insuline acylee par un acide gras
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US7378390B2 (en) * 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
BR0215029A (pt) * 2001-12-20 2005-12-20 Lilly Co Eli Molécula de insulina, uso da mesma, composição, uso desta, microcristal, processo para prepará-lo, uso deste, e, métodos para preparar uma molécula de insulina, para tratar hiperglicemia, e para tratar diabetes mellitus
EP1620465A2 (fr) * 2003-04-29 2006-02-01 Eli Lilly And Company Analogues de l'insuline ayant une action prolongee
EP2131723B1 (fr) * 2007-03-19 2013-07-24 Insuline Medical Ltd. Dispositif pour mesure de substance
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
WO2009081262A1 (fr) 2007-12-18 2009-07-02 Insuline Medical Ltd. Dispositif d'administration de médicament doté d'un capteur pour un fonctionnement en boucle fermée
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
AU2008227875B2 (en) * 2007-03-19 2014-06-12 Insuline Medical Ltd. Drug delivery device
JP5694779B2 (ja) 2008-01-09 2015-04-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
JP5695909B2 (ja) * 2008-01-09 2015-04-08 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
RS56632B1 (sr) 2008-10-17 2018-03-30 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
CN102245137A (zh) 2008-11-07 2011-11-16 茵苏莱恩医药有限公司 用于药物递送的装置和方法
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
EP2498801B1 (fr) 2009-11-13 2018-01-24 Sanofi-Aventis Deutschland GmbH COMPOSITION PHARMACEUTIQUE COMPRENANT desPro36Exendin-4(1-39)-Lys6-NH2 ET DE LA MÉTHIONINE
RU2546520C2 (ru) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CA2846413C (fr) 2011-08-29 2021-11-02 Sanofi-Aventis Deutschland Gmbh Combinaison pharmaceutique destinee a etre utilisee dans le controle de la glycemie chez des patients souffrant du diabete de type 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
HK1214829A1 (zh) 2013-05-02 2016-08-05 Glaxosmithkline Intellectual Property Development Limited 治疗肽
CR20170314A (es) 2014-12-12 2017-10-20 Sanofi Aventis Deutschland Formulación de relación fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN106323840A (zh) * 2016-09-13 2017-01-11 西南石油大学 一种页岩孔隙度测量方法
CN109735589B (zh) * 2019-01-02 2020-07-10 珠海冀百康生物科技有限公司 一种胰岛素DesB30的制备方法
CN113773398B (zh) * 2020-06-10 2023-05-23 宁波鲲鹏生物科技有限公司 一种德谷胰岛素衍生物及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
US4343898A (en) * 1980-02-11 1982-08-10 Novo Industri A/S Process for preparing esters of human insulin
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung

Also Published As

Publication number Publication date
JPH04503808A (ja) 1992-07-09
AU637365B2 (en) 1993-05-27
GR900100206A (el) 1991-07-31
ATE116661T1 (de) 1995-01-15
DE69015811T2 (de) 1995-05-11
EP0463072B1 (fr) 1995-01-04
FI914419A0 (fi) 1991-09-19
GR1002545B (el) 1997-01-28
DE69015811D1 (de) 1995-02-16
IE66564B1 (en) 1996-01-24
DK134189D0 (da) 1989-03-20
PT93502B (pt) 1996-02-29
US5430016A (en) 1995-07-04
NZ232953A (en) 1992-10-28
EP0463072A1 (fr) 1992-01-02
AU5344890A (en) 1990-10-22
WO1990011299A1 (fr) 1990-10-04
CN1045793A (zh) 1990-10-03
ES2068384T3 (es) 1995-04-16
PT93502A (pt) 1990-11-07
FI914419A7 (fi) 1991-09-19
NO300640B1 (no) 1997-06-30
DK0463072T3 (da) 1995-06-12
CA2049961A1 (fr) 1990-09-21
HUT58349A (en) 1992-02-28
IE901004L (en) 1990-09-20
DD298788A5 (de) 1992-03-12
NO913687L (no) 1991-11-19
NO913687D0 (no) 1991-09-19
KR920701250A (ko) 1992-08-11
IL93792A0 (en) 1990-12-23
YU53290A (sh) 1992-12-21
HU902706D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
ZA902086B (en) Novel insulin compounds
HUT56558A (en) Process for producing oxetanones
AU4799793A (en) Beta -aminoalkyl and beta -n-peptidylaminoalkyl boronic acids
GR3019425T3 (en) Hydrochlorofluorocarbon azeotropic or azeotropic-like mixture
GR3020961T3 (en) Endothelin antagonist
ATE169678T1 (de) Stabilisierte enzyme
AU6954887A (en) Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use
HU9401584D0 (en) Preparation of substituted piperidines
TW358806B (en) Process for the preparation of an alkylimidazolidone (meth)acrylate
AU3189997A (en) Method for producing peptides
ZA858169B (en) New adamantanamine derivatives,processes for their preparation and drugs in which they are present
ES8504679A1 (es) Procedimiento para la preparacion de derivados de insulina
IL74114A0 (en) Process for the preparation of alkanephosphonous acids
IL130470A0 (en) Process for the preparation of heteroaryl-zinc halides
GR3032427T3 (en) An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
MX173831B (es) Compuestos de naftil-azo-pirazolona y procedimiento para la preparacion de los mismos
HUT71095A (en) A process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
IE890498L (en) Process for the diacylation of compounds containing two aromatic rings
DE69608260D1 (en) Wässrige spectinomycinborat-auflösung
ES8702900A1 (es) Procedimiento de obtencion de un compuesto de guanidiltia- zol, util como inhibidor de secrecion gastrica
TH2351A (th) อนุพันธ์ของไดเบนโซฟิแรน